New platform of preloaded intraocular lenses
BAUSCH + LOMB has announced the launch of a new platform of preloaded intraocular lenses LUXSMART™ AND LUXGOOD™, which feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology.
LuxSmart™ and LuxGood™ comprise a hydrophobic material and represent the launch of a new platform for Bausch + Lomb, forming part of a complete range of innovative IOLs. A toric version using the same platform will also become available, in addition to the monofocal and PC-IOLs, according to the company.
“With the introduction of LuxSmart™, we are happy to access the presbyopia market with truly innovative premium IOL designs, avoiding the usual dysphotopsic phenomena that can compromise patient vision with typical diffractive optics” said Luc Bonnefoy Vice President Surgical International, Bausch + Lomb. “The Pure Refractive Optics Technology (PRO Technology) represents a great opportunity for patients to experience the benefits of presbyopia-correcting IOLs, but without the discomfort of dysphotopsic symptoms,” said Laura Pérez, Cataract & High-Tech Marketing Manager International, Bausch + Lomb.
https://www.bauschsurgical.eu/
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.